Knowledge (XXG)

Talk:Oncotype DX Colon Cancer Assay

Source šŸ“

215: 121: 163: 177: 152: 92: 21: 310:. Acebulf, in an edit summary, seems to indicate that this now meets the GNG, and Kvng contested a PROD. Is there consensus to skip AfD? I've looked through the first four sources and none mention "Oncotype DX Colon Cancer Assay" ā€“ most mention a breast cancer assay and one doesn't mention either. I will keep looking but if you could please provide the 411:
I don't have any solid sourcing that would meet GNG for this, but an argument could be made for the Oncotype DX series of test as a whole. That page is salted. Even if that's the solution, I think it's best to start over because this one is an outdated advertisement. I removed the "no GNG" part of
268:
I am an employee of Genomic Health and Oncotype DX Colon Cancer Assay is our product. However, we have taken great care to write this article to be neutral in tone. We have followed all of the guidelines given regarding citations and non-promotion. This is my full disclosure
345:
two days back, and didn't really understand what it meant, but preferred the PRODer to pitch in. Did it mean Kvng is contesting the deletion (and is there a reason?) or the PROD is no longer valid as it was contested (by someone else)?
366:
You're right, it seems I misunderstood "Restore without prejudice to AfD". However, I would like to hear from Acebulf and Kvng, especially the latter, because they have both indicated that deletion is not needed.
459:
Thank you all for your help. I think this article needs to be stubified or TNTed, but I do not have the capacity to take that on right now (determine what is relevant to keep and what is too much advertising).
425:
I'm not familiar with the subject matter, but searching for the title on Google Scholar quickly turned up multiple results from academic papers with the name in the title, themselves cited a few dozen times:
188:. The project works to allow users to contribute quality articles and media files to the encyclopedia and track their progress as they are developed. To participate, please visit the 102: 189: 184: 157: 397:. Based on that description, the justification for my deprod was that this did not appear to be a simple, uncontroversial deletion that prod is intended for. ~ 492: 233: 98: 341:
nominated at AfD. Acebulf in the edit summary talked about GNG for Oncotype DX, and not Oncotype DX Colon Cancer Assay. I had seen Kvng's
497: 487: 132: 57: 27: 41: 71: 227: 162: 138: 120: 430: 91: 303:
The outcome of the RfD discussion that restored this article was "Restore without prejudice to AfD",
223: 469: 376: 323: 281: 386: 258: 252: 77: 311: 20: 35: 433: 473: 445: 420: 406: 380: 357: 327: 285: 427: 306: 462: 369: 316: 274: 461: 402: 368: 315: 273: 65: 481: 438: 353: 413: 390: 296: 50: 31: 385:
I don't have a position on whether this should be deleted. I have not done any
214: 398: 300: 61: 47:
Advertisement. Fails GNG. Former BLAR, reinstated as conclusion of an RfD (
412:
the prod for that reason. Kvng's assessment is fair. No objection to AfD.
348: 333:
Some points: "Restore without prejudice to AfD" does not indicate it
261:, who wrote 82% of this page, declared a conflict of interest here. 176: 151: 395:
Advertisement. Former BLAR, reinstated as conclusion of an RfD
114: 86: 15: 213: 262: 222:
This article was accepted on 23 May 2012 by reviewer
389:
searches or evaluation of cited sources. The reason
305:which it should have been immediately nominated at 343:Deletion contested, not an uncotroversial deletion 198:Knowledge (XXG):WikiProject Articles for creation 266: 8: 118: 201:Template:WikiProject Articles for creation 182:This article was reviewed by member(s) of 146: 99:Knowledge (XXG):Redirects for discussion 148: 394: 342: 314:you found, that would save some time. 7: 493:AfC submissions by date/23 May 2012 137:It is of interest to the following 14: 264:Their full disclosure is below: 185:WikiProject Articles for creation 80:, not an uncotroversial deletion) 74:) on 2024-05-10 with the comment: 44:) on 4 May 2024Ā with the comment: 175: 161: 150: 119: 107:Restore without prejudice to AfD 101:on 10 April 2024. The result of 90: 19: 1: 97:This page was nominated at 514: 221: 170: 145: 498:Accepted AfC submissions 488:Start-Class AfC articles 474:08:40, 15 May 2024 (UTC) 446:00:12, 13 May 2024 (UTC) 421:15:36, 12 May 2024 (UTC) 407:13:55, 12 May 2024 (UTC) 381:10:43, 12 May 2024 (UTC) 358:10:32, 12 May 2024 (UTC) 328:10:20, 12 May 2024 (UTC) 286:10:03, 12 May 2024 (UTC) 393:gave in their prod was 271: 218: 127:This article is rated 251:COI declaration from 217: 195:Articles for creation 192:for more information. 158:Articles for creation 131:on Knowledge (XXG)'s 28:proposed for deletion 219: 133:content assessment 78:Deletion contested 248: 247: 244: 243: 240: 239: 113: 112: 85: 84: 81: 54: 53: 505: 466: 418: 373: 356: 351: 320: 278: 206: 205: 202: 199: 196: 179: 172: 171: 166: 165: 164: 154: 147: 130: 124: 123: 115: 94: 87: 76: 48: 46: 23: 16: 513: 512: 508: 507: 506: 504: 503: 502: 478: 477: 437: 414: 352: 347: 293: 256: 224:GraemeĀ Bartlett 203: 200: 197: 194: 193: 160: 128: 12: 11: 5: 511: 509: 501: 500: 495: 490: 480: 479: 457: 456: 455: 454: 453: 452: 451: 450: 449: 448: 435: 361: 360: 292: 289: 255: 249: 246: 245: 242: 241: 238: 237: 220: 210: 209: 207: 180: 168: 167: 155: 143: 142: 136: 125: 111: 110: 103:the discussion 95: 83: 82: 75: 55: 45: 26:This page was 24: 13: 10: 9: 6: 4: 3: 2: 510: 499: 496: 494: 491: 489: 486: 485: 483: 476: 475: 471: 467: 465: 447: 444: 443: 442: 434: 431: 428: 424: 423: 422: 419: 417: 410: 409: 408: 404: 400: 396: 392: 388: 384: 383: 382: 378: 374: 372: 365: 364: 363: 362: 359: 355: 350: 344: 340: 336: 332: 331: 330: 329: 325: 321: 319: 313: 309: 308: 302: 298: 290: 288: 287: 283: 279: 277: 270: 265: 263: 260: 254: 250: 235: 232: 229: 225: 216: 212: 211: 208: 191: 187: 186: 181: 178: 174: 173: 169: 159: 156: 153: 149: 144: 140: 134: 126: 122: 117: 116: 108: 104: 100: 96: 93: 89: 88: 79: 73: 70: 67: 63: 59: 52: 43: 40: 37: 33: 29: 25: 22: 18: 17: 463: 458: 440: 439: 415: 370: 338: 334: 317: 304: 294: 275: 272: 267: 259:User:GHI MSM 257: 253:User:GHI MSM 230: 204:AfC articles 190:project page 183: 139:WikiProjects 106: 68: 49:proposed by 38: 339:immediately 129:Start-class 482:Categories 337:have been 464:Toadspike 387:WP:BEFORE 371:Toadspike 318:Toadspike 276:Toadspike 269:statement 58:contested 441:Rosguill 436:signed, 312:WP:THREE 291:PROD/AfD 234:contribs 72:contribs 42:contribs 416:Acebulf 391:Acebulf 297:Acebulf 56:It was 51:Acebulf 32:Acebulf 335:should 135:scale. 470:talk 403:talk 399:Kvng 377:talk 324:talk 301:Kvng 282:talk 228:talk 105:was 66:talk 62:Kvng 36:talk 349:Jay 307:AfD 60:by 30:by 484:: 472:) 432:, 429:, 405:) 379:) 354:šŸ’¬ 326:) 284:) 236:). 468:( 401:( 375:( 322:( 299:@ 295:@ 280:( 231:Ā· 226:( 141:: 109:. 69:Ā· 64:( 39:Ā· 34:(

Index

Proposed deletion
proposed for deletion
Acebulf
talk
contribs
Acebulf
contested
Kvng
talk
contribs
Deletion contested
Redirects for discussion
Knowledge (XXG):Redirects for discussion
the discussion

content assessment
WikiProjects
WikiProject icon
Articles for creation
WikiProject icon
WikiProject Articles for creation
project page
Note icon
GraemeĀ Bartlett
talk
contribs
User:GHI MSM
User:GHI MSM

Toadspike

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

ā†‘